Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel

PARSIPPANY, N.J., and MONTREAL, May 1, 2013 -- (Healthcare Sales & Marketing Network) -- Actavis, Inc. (ACT), and Valeant Pharmaceuticals International, Inc. (VRX) (VRX) today announced that Actavis Specialty Brands (the "Company") has acquired ... Biopharmaceuticals, AcquisitionsValeant Pharmaceuticals, Actavis, Metronidazole
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news